Ballard Spahr, Within3, and JB Ashtin are presenting a webinar on the use of virtual, private communities as a platform to improve clinical trial communication between study sponsors and sites. This platform was created in response to environmental trends and the market pressures that clinical operations teams face as they struggle to balance the urgency of bringing new therapies to market faster and more efficiently, while conducting ethical, quality research around the globe.

More than 80 percent of clinical trials experience delays from one to six months, costing pharmaceutical companies upwards of $35,000 per day, per trial (, July 2011). Online clinical communities are a measurable way for clinical operations teams to shorten trial length and bring lifesaving medications to the patients who are waiting.

Key topics will focus on the value of using community technology to improve clinical trial/registry services, communication, management, and outcomes. Attendees will learn how online communities can: 

  • Enhance communication by streamlining multiple pathways into one accessible work site 
  • Maintain consistent awareness of trial objectives 
  • Centralize trial information and share updates across trial sites 
  • Maintain a repository of study forms and documents, key analytics, and information resources 
  • Optimize efforts of operational staff when working with trial sites 
  • Augment and extend face-to-face investigator meetings 
  • Leverage compliance with regulatory guidelines and best practices in litigation


2:00 PM - 3:00 PM   | Webinar


Lance P. Hill, Director and CEO, Within3
Joan Bradley, PharmD, President and CEO, JB Ashtin
Philip N. Yannella, J.D., Partner, Ballard Spahr